Putney Adds Experienced Scientist to Lead Product Development
Date: March 23, 2010
Portland, Maine—March 23, 2010— Putney, Inc., a rapidly growing pet pharmaceutical company, today announced that Anthony Lucas, BVMS (Hons), Ph.D., has joined the company as Director of Product Development. As the leader of development efforts Dr. Lucas will be responsible for technical evaluation of product opportunities, formulation development with outside partners, Putney’s clinical program, and work closely with Regulatory Affairs to ensure the high quality of scientific submissions required for approval from the FDA Center for Veterinary Medicine.
Prior to joining Putney Dr. Lucas was the Group Leader Companion Animal Acquisitions for Elanco, a division of Eli Lilly, where he developed and implemented the strategy to deliver growth through targeted product acquisitions. Dr. Lucas has also held positions as a due diligence leader, senior research scientist, as a practicing veterinarian, and is an officer of the American Association of Veterinary Pharmacology & Therapeutics.
Jean Hoffman, president and CEO of Putney believes the addition of Dr. Lucas is a significant milestone in Putney’s plans for growth. “With Dr. Lucas leading development efforts, Putney has increased our scientific capabilities to overcome the challenges of developing drugs for dogs and cats and bring more products to companion animal veterinarians,” says Hoffman.
Dr. Lucas supports Putney’s mission to be the leading generic and specialty pharmaceutical company serving companion animal veterinarians. “As a veterinarian it is rewarding to lead a team developing high quality, affordable generics for practitioners—to help keep prescriptions in their pharmacies, and to enhance compliance because pet owners can afford the full course of treatment,” said Dr. Lucas.
Currently 94% of FDA approved drugs for pets lack generic equivalents. Putney’s pipeline includes products requested by veterinarians in the anti-infective, pain, parasiticide, anesthesia & sedation, and dermatological therapeutic categories.
About Putney
Putney, Inc.is a pharmaceutical company that listens to companion animal veterinarians and responds to their needs—making affordable drugs available, and developing products that address common concerns such as dosing and palatability. Putney empowers veterinarians with prescribing choices that allow them to pursue the best course of treatment for improved compliance, more satisfied pet owners and happy pets. Learn more at www.putneyvet.com.